Skip to main content
Log in

Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common disorder with estimated prevalence of 5% in children and 3.4% in adults. Psychiatric disorders are a frequent concomitant feature. Restless legs syndrome (RLS) may mimic the symptoms of ADHD. The aim of the study is to evaluate whether the presence of RLS predicts occurrence of psychiatric disorders in parents of children with ADHD. Thirty-seven parents of 26 children with ADHD were examined for RLS and for lifetime prevalence rates of psychiatric disorders and personality disorders based on the Structured Clinical Interview for DSM-IV Diagnoses (SCID). Prevalence rates in parents were 29.7% for RLS, 67.6% for Axis I and 40.5% for Axis II disorders. Mothers revealed higher rates for depression, anxiety disorders and ADHD than fathers, whereas personality disorders occurred at higher rates in fathers. The presence of RLS predicted a diagnosis of ADHD (odds ratio (OR) 21.9), agoraphobia (OR = 20.4) and any anxiety disorder (OR = 8.5). Although limited by the small sample size, we found evidence for increased rates of cluster B personality disorders (OR = 59.3) in parents with RLS. All parents of the latter group (100%) reported a positive family history of psychiatric disorders which was not the case in parents without RLS (69.2%) excluding the index children with ADHD. RLS seems to indicate increased vulnerability for psychiatric disorders, i.e., ADHD and anxiety disorders, in a subgroup of parents from ADHD children. Synaptic dysfunction affecting dopaminergic transmission among other transmitter systems may be a common final pathway related to the phenotypic spectrum of ADHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dopfner M, Breuer D, Wille N et al (2008) How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample–results of the BELLA study. Eur Child Adolesc Psychiatry 17(Suppl 1):59–70

    Article  PubMed  Google Scholar 

  2. Fayyad J, De Graaf R, Kessler R et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409

    Article  PubMed  CAS  Google Scholar 

  3. Faraone SV, Spencer TJ, Montano CB et al (2004) Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch Intern Med 164:1221–1226

    Article  PubMed  Google Scholar 

  4. Faraone SV, Antshel KM (2008) Diagnosing and treating attention-deficit/hyperactivity, disorder in adults. World Psychiatry 7:131–136

    PubMed  Google Scholar 

  5. Thapar A, Holmes J, Poulton K et al (1999) Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105–111

    Article  PubMed  CAS  Google Scholar 

  6. Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323

    Article  PubMed  CAS  Google Scholar 

  7. Morrison JR, Stewart MA (1971) A family study of the hyperactive child syndrome. Biol Psychiatry 3:189–195

    PubMed  CAS  Google Scholar 

  8. Faraone SV, Doyle AE, Mick E et al (2001) Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052–1057

    Article  PubMed  CAS  Google Scholar 

  9. Lowe N, Kirley A, Hawi Z et al (2004) Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 74:348–356

    Article  PubMed  CAS  Google Scholar 

  10. Retz W, Rosler M, Kissling C et al (2008) Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J Neural Transm 115:323–329

    Article  PubMed  CAS  Google Scholar 

  11. Biederman J, Faraone SV, Spencer T et al (1993) Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792–1798

    PubMed  CAS  Google Scholar 

  12. Barkley RA, Murphy KR, Kwasnik D (1996) Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 98:1089–1095

    PubMed  CAS  Google Scholar 

  13. Shekim WO, Asarnow RF, Hess E et al (1990) A Clinical and Demographic Profile of a Sample of Adults with Attention-Deficit Hyperactivity Disorder, Residual State. Compr Psychiat 31:416–425

    Article  PubMed  CAS  Google Scholar 

  14. Rösler M, Retz W, Yaqoobi K, Burg E, Retz-Junginger P (2009) Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci 259(2):98–105

    Article  PubMed  Google Scholar 

  15. Mannuzza S, Klein RG, Bessler A et al (1998) Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155:493–498

    PubMed  CAS  Google Scholar 

  16. Comings DE (1994) Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. Drug Alcohol Depend 35:1–16

    Article  PubMed  CAS  Google Scholar 

  17. Ghanizadeh A, Mohammadi MR, Moini R (2008) Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD. J Atten Disord 12:149–155

    Article  PubMed  Google Scholar 

  18. Faraone SV, Wilens TE, Petty C et al (2007) Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict 16(Suppl 1):24–32

    Article  PubMed  Google Scholar 

  19. Wilens TE (2004) Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 27:283–301

    Article  PubMed  Google Scholar 

  20. Cortese S, Konofal E, Lecendreux M et al (2005) Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 28:1007–1013

    PubMed  Google Scholar 

  21. Konofal E, Cortese S, Marchand M et al (2007) Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med 8:711–715

    Article  PubMed  Google Scholar 

  22. Allen RP, Stillman P, Myers AJ (2010) Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med 11:31–37

    Article  PubMed  Google Scholar 

  23. Bjorvatn B, Leissner L, Ulfberg J et al (2005) Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 6:307–312

    Article  PubMed  Google Scholar 

  24. Clardy SL, Wang X, Boyer PJ et al (2006) Is ferroportin-hepcidin signaling altered in restless legs syndrome? J Neurol Sci 247:173–179

    Article  PubMed  CAS  Google Scholar 

  25. Winkelmann J, Wetter TC, Collado-Seidel V et al (2000) Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 23:597–602

    PubMed  CAS  Google Scholar 

  26. Desai AV, Cherkas LF, Spector TD et al (2004) Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res 7:589–595

    Article  PubMed  Google Scholar 

  27. Rothdach AJ, Trenkwalder C, Haberstock J et al (2000) Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in augsburg elderly. Neurology 54:1064–1068

    PubMed  CAS  Google Scholar 

  28. Winkelmann J, Prager M, Lieb R et al (2005) “Anxietas tibiarum”: Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 252:67–71

    Article  PubMed  CAS  Google Scholar 

  29. Phillips B, Hening W, Britz P et al (2006) Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 129:76–80

    Article  PubMed  Google Scholar 

  30. Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV. Hogrefe-Verlag, Göttingen

    Google Scholar 

  31. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH et al (2002) Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 73(9):830–838

    Article  PubMed  CAS  Google Scholar 

  32. Roesler M, Retz W, Retz-Junginger P et al (2004) Tools fort he diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire (ADHS-SB) and diagnostic checklist (ADHS-DC). Nervenarzt 75:888–895

    Google Scholar 

  33. Walters AS, LeBrocq C, Dhar A et al (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4:121–132

    Article  PubMed  Google Scholar 

  34. Endicott J, Andreasen N, Spitzer RL (1978) Family history research diagnostic criteria. Biometrics Research, New York Psychiatric Institute, New York

    Google Scholar 

  35. Mosko S, Zetin M, Glen S et al (1989) Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol 45:51–60

    Article  PubMed  CAS  Google Scholar 

  36. Finckh U, Rommelspacher H, Kuhn S et al (1997) Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7:271–281

    Google Scholar 

  37. Renner TJ, Gerlach M, Romanos M et al (2008) Neurobiology of attention-deficit hyperactivity disorder. Nervenarzt 79:771–781

    Article  PubMed  CAS  Google Scholar 

  38. Maheswaran M, Kushida CA (2006) Restless legs syndrome in children. MedGenMed 8:79

    PubMed  Google Scholar 

  39. Earley CJ (2003) Clinical practice. Restless legs syndrome. N Engl J Med 2(348):2103–2109

    Article  Google Scholar 

  40. Rösler M, Fischer R, Ammer R, Ose C, Retz W (2009) A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 259:120–129

    Article  PubMed  Google Scholar 

  41. Engert V, Pruessner JC (2008) Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate. Curr Neuropharmacol 6:322–328

    Article  PubMed  CAS  Google Scholar 

  42. Wood D, Reimherr F, Wender PH (1982) Effects of levodopa on attention deficit disorder, residual type. Psychiatry Res 6:13–20

    Article  PubMed  CAS  Google Scholar 

  43. Ernst M, Liebenauer LL, Tebeka D et al (1997) Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacol 16:276–284

    Article  CAS  Google Scholar 

  44. Mohammadi MR, Ghanizadeh A, Alaghband-Rad J et al (2004) Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial. J Child Adolesc Psychopharmacol 14:418–425

    Article  PubMed  Google Scholar 

  45. Walters AS, Mandelbaum DE, Lewin DS et al (2000) Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic therapy study group. Pediatr Neurol 22:182–186

    Article  PubMed  CAS  Google Scholar 

  46. Hamilton SS, Armando J (2008) Oppositional defiant disorder. Am Fam Physician 78:861–866

    PubMed  Google Scholar 

  47. Soderstrom H, Blennow K, Sjodin AK et al (2003) New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits. J Neurol Neurosurg Psychiatry 74:918–921

    Article  PubMed  CAS  Google Scholar 

  48. Cyr M, Brown CS (1998) Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder. Drugs 56:215–223

    Article  PubMed  CAS  Google Scholar 

  49. Silver LB (1999) Alternative (nonstimulant) medications in the treatment of attention deficit hyperactivity disorder in children. Pediatr Clin North Am 46:965–975

    Article  PubMed  CAS  Google Scholar 

  50. Mohammadi MR, Kashani L, Akhondzadeh S et al (2004) Efficacy of theophylline compared to methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents: a pilot double-blind, randomized trial. J Clin Pharm Ther 29:139–144

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rebekka Lencer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steinlechner, S., Brüggemann, N., Sobottka, V. et al. Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD. Eur Arch Psychiatry Clin Neurosci 261, 285–291 (2011). https://doi.org/10.1007/s00406-010-0140-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-010-0140-z

Keywords

Navigation